Ex-Vivo Organ Perfusion Market

Global Ex-Vivo Organ Perfusion Market Size, Trends & Analysis - Forecasts to 2026 By Perfusion Technology (Hypothermic Perfusion Technology and Normothermic Perfusion Technology), By Component (Organ Perfusion Machine, and Organ Preservation Solutions & Services), By Organ Type (Heart, Liver, Kidney, and Lung), By Application (Organ Transplantation Surgery, and Drug Research Application), By End-User (Organ Transplant Specialist Hospitals, Organ Banks, and Pharmaceutical Research Organizations), By Competitive Landscape Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on May 9 2022 with the latest and most recent market numbers

Ex-Vivo Organ Perfusion Market Insights

The global ex-vivo organ perfusion market is projected to grow at a CAGR value of around 7.2% during the forecast period of 2021 to 2026.

Hypothermic machine perfusion is the latest advancements made in the organ transportation field. It’s an emerging technology that helps to limit the ischemia/reperfusion injury to the donor organ during allograft preservation and leads to hassle-free organ transplantation.

On the other hand, the normothermic perfusion technology is to recreate an artificial physiological environment and maintain a normal temperature and provide essential substrates for cellular metabolism, oxygen, and nutrition to the donor organ during transportation. With the help of these technologies, the donor organ is constantly subjected to perfused oxygenated blood, medications, and nutrients to maintain the normal body temperature and pressure. These two technologies have changed the look at the ex-vivo organ perfusion market.

Rising cases of multi-organ failure due to genetic disorders, infectious disease, cardiac failure cases, and post-surgical effects, rising need for liver and kidney transplant surgeries, rapidly growing geriatric patient population, and the rising number of organ donors will help the market grow rapidly.

Other factors supporting the growth of the ex-vivo organ perfusion market are the high prevalence of cardiovascular and respiratory diseases, rising investments in cell-based research, and rising activities in biologics manufacturing.

However, the high cost of organ transplantation, ethical concerns regarding stem cell research activities, and the high cost of cell-based research are expected to restrain the growth of this market during the forecast period

Moreover, increasing awareness and the importance of organ donation with the help of government and private initiators will also support the market growth from 2021 to 2026. For instance, the European region celebrates 12th October European Day for Organ Donation and Transplantation and successfully registers members for organ donations, and spreads awareness regarding the importance of organ transplants.

However, the expensive transplantation surgery and lack of facilities regarding organ preservation and transportation in specific developing regions are hampering the growth of the market.

The COVID-19 impact on the healthcare industry was fairly well, but its impact on non-urgent surgeries was negative which affected the market growth to a large extent. Many hospitals, clinics, and other healthcare organization shifted their focus in managing COVID-19 patients and de-prioritized transplant surgeries. A total of 5,725 living donor transplants were performed in 2020, which is 22.6% less than the record of 7,397 surgeries performed in 2019.

global ex vivo organ perfusion market

Ex-Vivo Organ Perfusion Market: By Perfusion Technology

Based on perfusion technology, the market is segmented into hypothermic perfusion technology and normothermic perfusion technology. The hypothermic machine perfusion segment accounted for the largest share of the market and is expected to maintain the dominant position throughout the forecast period of 2021 to 2026. Added advantages offered by hypothermic perfusion technology over normothermic perfusion technology, such as increased survival rate of the donor graft, reduced vasospasm, and high ability to provide metabolic support throughout the transportation procedure. However, the normothermic perfusion technology will be the fastest growing segment in the market.

Ex-Vivo Organ Perfusion Market: By Component

Based on components, the market is segmented into organ perfusion machines, and organ preservation solutions & services. The organ preservation solutions & services will be the fastest growing segment. The growth is due to the rising need for preservation solutions clubbed with the increasing number of organ transplantation surgeries.

Ex-Vivo Organ Perfusion Market: By Organ Type

Based on organ type, the market is segmented into Heart, Liver, Kidney, and Lung. Owing to the increasing demand for liver transplants across the globe, the segment of liver transplants will be the largest shareholder in the market. The kidney transplant segment will be the fastest growing segment from 2021 to 2026.

Ex-Vivo Organ Perfusion Market: By Application

Based on application, the market is segmented into organ transplantation surgery, and drug research applications. The organ transplantation surgery segment will be the largest shareholder segment as per the application outlook in the market. Rapidly rising need for organ transplants due to multiple-organ failure, and an increasing number of organ donors across the globe are some of the factors supporting the growth of this application segment.

Ex-Vivo Organ Perfusion Market: By End-User

Based on end-user, the market is segmented into organ transplant specialist hospitals, organ banks, and pharmaceutical research organizations. The organ transplant specialist hospitals will be the largest segment in the market. Rising awareness regarding the importance of the latest ex-vivo organ perfusion technologies, and an increasing number of patient registration for organ transplant surgeries will support the growth of the market.

asia pacific ex vivo organ perfusion market

Ex-Vivo Organ Perfusion Market: By Region

As per the geographical analysis, the ex-vivo organ perfusion market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America).

North America (the United States, Canada, and Mexico) will have a dominant share in the market from 2021 to 2026. The Asia Pacific segment will be growing the fastest owing to the high prevalence of multiple-organ failure cases and the rising geriatric patient population.

Ex-Vivo Organ Perfusion Market Share and Competitor Analysis

Paragonix Technologies, 21st Century Medicine, Waters Medical Systems, Avionord, Getinge AB, Medtronic, Lifeline Scientific, Organox Limited, Xvivo Perfusion AB, Transmedics, Bridge to Life Limited, Organ Assist, Ebers, Essential Pharmaceuticals,  Dr. Franz Köhler Chemie GmbH, Preservation Solutions, Carnamedica, Transplant Biomedicals, Organ Preservation Solutions, and Institut Georges Lopez among others are the key players in the ex-vivo organ perfusion market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Methodology

1.1    Market Scope & Definitions

1.2    Estimates & Forecast Calculation

1.3    Historical Data Overview and Validation

1.4    Data Sources

1.4.1    Secondary

1.4.2    Primary

Chapter 2   Report Outlook

2.1    Ex-Vivo Organ Perfusion Industry Overview, 2019-2026

2.1.1    Industry Overview

2.1.2    Perfusion Technology Overview

2.1.3    Organ Type Overview

2.1.4    End-User Overview

2.1.5    Application Overview

2.1.6    Component Overview

2.1.7    Regional Overview

Chapter 3   Ex-Vivo Organ Perfusion Market Trends

3.1    Market Segmentation

3.2    Industry Background, 2019-2026

3.3    Market Key Trends

3.3.1    Positive Trends

3.3.1.1    Rising organ transplant surgeries

3.3.2    Industry Challenges

3.3.2.1    Lack of awareness related to hypothermic perfusion technology and normothermic perfusion technology in developing and low-income countries  

3.4    Prospective Growth Scenario

3.4.1    Perfusion Technology Growth Scenario

3.4.2    Organ Type Growth Scenario

3.4.3    End-User Growth Scenario

3.4.4    Application Growth Scenario

3.4.5    Component Scenario

3.4.6    Clinical Trial Phase Scenario

3.5    COVID-19 Influence over Industry Growth

3.6    Porter’s Analysis

3.7    PESTEL Analysis

3.8    Value Chain & Supply Chain Analysis

3.9    Regulatory Framework

3.9.1    North America

3.9.2    Europe

3.9.3    APAC

3.9.4    LATAM

3.9.5    MEA

3.10    Application Overview

3.11    Market Share Analysis, 2020

3.11.1    Company Positioning Overview, 2020

Chapter 4   Ex-Vivo Organ Perfusion Market, By Perfusion Technology

4.1    Perfusion Technology Outlook

4.2    Hypothermic Perfusion Technology

4.2.1    Market Size, By Region, 2019-2026 (USD Million)

4.3    Normothermic Perfusion Technology

4.3.1    Market Size, By Region, 2019-2026 (USD Million)

Chapter 5   Ex-Vivo Organ Perfusion Market, By Organ Type

5.1    Organ Type Outlook

5.2   Heart

5.2.1    Market Size, By Region, 2019-2026 (USD Million)

5.3    Liver

5.3.1    Market Size, By Region, 2019-2026 (USD Million)

5.4    Kidney

5.4.1    Market Size, By Region, 2019-2026 (USD Million)

5.5    Lung

5.5.1    Market Size, By Region, 2019-2026 (USD Million)

Chapter 6   Ex-Vivo Organ Perfusion Market, By End-User

6.1    Organ Transplant Specialist Hospitals

6.1.1    Market Size, By Region, 2019-2026 (USD Million)

6.2    Organ Banks

6.2.1    Market Size, By Region, 2019-2026 (USD Million)

6.3    Pharmaceutical Research Organizations

6.3.1    Market Size, By Region, 2019-2026 (USD Million)

Chapter 7   Ex-Vivo Organ Perfusion Market, By Application

7.1    Organ Transplantation Surgery

7.1.1    Market Size, By Region, 2019-2026 (USD Million)

7.2    Drug Research Application

7.2.1    Market Size, By Region, 2019-2026 (USD Million)

Chapter 8   Ex-Vivo Organ Perfusion Market, By Component

8.1    Organ Perfusion Machine

         8.1.1    Market Size, By Region, 2019-2026 (USD Million)

8.2    Organ Preservation Solutions & Services

8.2.1    Market Size, By Region, 2019-2026 (USD Million)

Chapter 9   Ex-Vivo Organ Perfusion Market, By Region

9.1    Regional outlook

9.2    North America

9.2.1    Market Size, By Country 2019-2026 (USD Million)

9.2.2    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.2.3    Market Size, By Organ Type, 2019-2026 (USD Million)

9.2.4    Market Size, By End-User, 2019-2026 (USD Million)

9.2.5    Market Size, By Application, 2019-2026 (USD Million)

9.2.6    Market Size, By Component, 2019-2026 (USD Million)

9.2.7    U.S.

9.2.7.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.2.7.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.2.7.3    Market Size, By End-User, 2019-2026 (USD Million)

9.2.7.4    Market Size, By Application, 2019-2026 (USD Million)

          9.2.7.5    Market Size, By Component, 2019-2026 (USD Million)

9.2.8    Canada

9.2.8.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.2.8.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.2.8.3    Market Size, By End-User, 2019-2026 (USD Million)

9.2.8.4    Market Size, By Application, 2019-2026 (USD Million)

          9.2.8.5    Market Size, By Component, 2019-2026 (USD Million)

9.2.9    Mexico

9.2.9.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.2.9.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.2.9.3    Market Size, By End-User, 2019-2026 (USD Million)

9.2.9.4    Market Size, By Application, 2019-2026 (USD Million)

          9.2.9.5    Market Size, By Component, 2019-2026 (USD Million)

9.3    Europe

9.3.1    Market Size, By Country 2019-2026 (USD Million)

9.3.2    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.3.3    Market Size, By Organ Type, 2019-2026 (USD Million)

9.3.4    Market Size, By End-User, 2019-2026 (USD Million)

9.3.5    Market Size, By Application, 2019-2026 (USD Million)

9.3.6    Market Size, By Component, 2019-2026 (USD Million)

9.3.7    Germany

9.3.7.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.3.7.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.3.7.3    Market Size, By End-User, 2019-2026 (USD Million)

9.3.7.4    Market Size, By Application, 2019-2026 (USD Million)

          9.3.7.5    Market Size, By Component, 2019-2026 (USD Million)

9.3.8    UK

9.3.8.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.3.8.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.3.8.3    Market Size, By End-User, 2019-2026 (USD Million)

9.3.8.4    Market Size, By Application, 2019-2026 (USD Million)

          9.3.8.5    Market Size, By Component, 2019-2026 (USD Million)         

9.3.9    France

9.3.9.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.3.9.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.3.9.3    Market Size, By End-User, 2019-2026 (USD Million)

9.3.9.4    Market Size, By Application, 2019-2026 (USD Million)

          9.3.9.5    Market Size, By Component, 2019-2026 (USD Million)          

9.3.10    Italy

9.3.10.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.3.10.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.3.10.3    Market Size, By End-User, 2019-2026 (USD Million)

9.3.10.4    Market Size, By Application, 2019-2026 (USD Million)

          9.3.10.5    Market Size, By Component, 2019-2026 (USD Million)

9.4    Asia Pacific

9.4.1    Market Size, By Country 2019-2026 (USD Million)

9.4.2    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.4.3    Market Size, By Organ Type, 2019-2026 (USD Million)

9.4.4    Market Size, By End-User, 2019-2026 (USD Million)

9.4.5   Market Size, By Application, 2019-2026 (USD Million)

9.4.6    Market Size, By Component, 2019-2026 (USD Million)

9.4.7    China

9.4.7.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.4.7.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.4.7.3    Market Size, By End-User, 2019-2026 (USD Million)

9.4.7.4    Market Size, By Application, 2019-2026 (USD Million)

          9.4.7.5    Market Size, By Component, 2019-2026 (USD Million)

9.4.8    India

9.4.8.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.4.8.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.4.8.3    Market Size, By End-User, 2019-2026 (USD Million)

9.4.8.4    Market Size, By Application, 2019-2026 (USD Million)

          9.4.8.5    Market Size, By Component, 2019-2026 (USD Million)

9.4.9    Japan

9.4.9.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.4.9.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.4.9.3    Market Size, By End-User, 2019-2026 (USD Million)

9.4.9.4    Market Size, By Application, 2019-2026 (USD Million)

          9.4.9.5    Market Size, By Component, 2019-2026 (USD Million)

9.5    MEA

9.5.1    Market Size, By Country 2019-2026 (USD Million)

9.5.2    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.5.3    Market Size, By Organ Type, 2019-2026 (USD Million)

9.5.4    Market Size, By End-User, 2019-2026 (USD Million)

9.5.5    Market Size, By Application, 2019-2026 (USD Million)

9.5.6    Market Size, By Component, 2019-2026 (USD Million)

9.5.7    Saudi Arabia

9.5.7.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.5.7.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.5.7.3   Market Size, By End-User, 2019-2026 (USD Million)

9.5.7.4   Market Size, By Application, 2019-2026 (USD Million)

          9.5.7.5    Market Size, By Component, 2019-2026 (USD Million)

            9.5.8    UAE

9.5.8.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.5.8.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.5.8.3    Market Size, By End-User, 2019-2026 (USD Million)

9.5.8.4    Market Size, By Application, 2019-2026 (USD Million)

          9.5.8.5    Market Size, By Component, 2019-2026 (USD Million)

   9.5.9    South Africa

9.5.9.1    Market Size, By Perfusion Technology, 2019-2026 (USD Million)

9.5.9.2    Market Size, By Organ Type, 2019-2026 (USD Million)

9.5.9.3    Market Size, By End-User, 2019-2026 (USD Million)

9.5.9.4    Market Size, By Application, 2019-2026 (USD Million)

          9.5.9.5    Market Size, By Component, 2019-2026 (USD Million)

Chapter 10   Company Landscape

10.1    Competitive Analysis, 2020

10.2    Paragonix Technologies

10.2.1    Company Overview

10.2.2    Financial Analysis

10.2.3    Strategic Positioning

10.2.4    Info Graphic Analysis

10.3    21st Century Medicine

10.3.1    Company Overview

10.3.2    Financial Analysis

10.3.3    Strategic Positioning

10.3.4    Info Graphic Analysis

10.4    Waters Medical Systems

10.4.1    Company Overview

10.4.2    Financial Analysis

10.4.3    Strategic Positioning

10.4.4    Info Graphic Analysis

10.5    Avionord

10.5.1    Company Overview

10.5.2    Financial Analysis

10.5.3    Strategic Positioning

10.5.4    Info Graphic Analysis

10.6    Getinge AB

10.6.1    Company Overview

10.6.2    Financial Analysis

10.6.3    Strategic Positioning

10.6.4    Info Graphic Analysis

10.7    Medtronic

10.7.1    Company Overview

10.7.2    Financial Analysis

10.7.3    Strategic Positioning

10.7.4    Info Graphic Analysis

10.8    Lifeline Scientific

10.10.1    Company Overview

10.10.2    Financial Analysis

10.10.3    Strategic Positioning

10.10.4    Info Graphic Analysis

10.11 Organox Limited

10.10.1    Company Overview

10.10.2    Financial Analysis

10.10.3    Strategic Positioning

10.10.4    Info Graphic Analysis

10.10    Others

10.10.1    Company Overview

10.10.2    Financial Analysis

10.10.3    Strategic Positioning

          10.10.4    Info Graphic Analysis

The Global Ex-Vivo Organ Perfusion Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Ex-Vivo Organ Perfusion Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy

Frequently Asked Questions

The global ex-vivo organ perfusion market is projected to grow at a CAGR value of around 7.2% during the forecast period [2021 to 2026].
Key and innovative vendors in the market include Paragonix Technologies, 21st Century Medicine, Waters Medical Systems, Avionord, Getinge AB, Medtronic, Lifeline Scientific, Organox Limited, Xvivo Perfusion AB, Transmedics, Bridge to Life Limited, Organ Assist, Ebers, Essential Pharmaceuticals, Dr. Franz Köhler Chemie GmbH, Preservation Solutions, Carnamedica, Transplant Biomedicals, Organ Preservation Solutions, and Institut Georges Lopez.
North America is estimated to hold the highest market share in the ex-vivo organ perfusion market.
The COVID-19 impact on healthcare industry was fairly well, but its impact on non-urgent surgeries was negative which affected the market growth to a large extent. Many hospitals, clinics and other healthcare organization shifted their focus in managing COVID-19 patients and de-prioritized transplant surgeries. A total of 5,725 living donor transplants were performed in 2020, which is a 22.6% less than the record of 7,397 surgeries performed in 2019.
Rising cases of multi-organ failure due to genetic disorders, infectious disease, cardiac failure cases, and post-surgical effects, rising need for liver and kidney transplant surgeries, rapidly growing geriatric patient population, and the rising number of organ donors will help the market grow rapidly.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius